Ted Blanchard serves as the Director of Product Management at Mercy BioAnalytics, Inc., starting in April 2024. Prior to this role, Ted worked as the Senior Manager of Global Product Management at Revvity from May 2023 to April 2024, focusing on delivering comprehensive solutions from research to diagnosis and treatment. Ted's extensive background in the diagnostics and biopharmaceutical industries includes positions such as Senior Manager of Global Strategic Marketing and Clinical Science Liaison at Oxford Immunotec, as well as various roles in clinical affairs at Alkermes, Vertex Pharmaceuticals, Seaside Therapeutics, and FoldRx. Ted holds an MBA in Health Sector Management and Marketing from the Questrom School of Business at Boston University and a BA in Finance from the Isenberg School of Management at UMass Amherst.